AVENUE THERAPEUTICS, INC.

ATXI · OTC · SIC 2834: Pharmaceutical Preparations
188
SEC Filings

Business Summary

Avenue Therapeutics, Inc. is a specialty pharmaceutical company focused on developing drug product candidates. Its primary pipeline includes IV tramadol, an intravenous formulation of the analgesic tramadol, and ATX-04. The company has no approved products for commercial sale. It previously held rights to AJ201 (licensed from AnnJi Pharmaceutical) and BAER101 (via Baergic Bio), both of which have been divested. Avenue is a majority-controlled subsidiary of Fortress Biotech, Inc.

Next Earnings

Q2 FY2026 — expected 2026-09-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionATXIdiscussed_in_filing Cybersecurity
topic_mentionATXIdiscussed_in_filing Trusted Computing
topic_mentionATXIdiscussed_in_filing Blockchain & Crypto
topic_mentionATXIdiscussed_in_filing Regulation
topic_mentionATXIdiscussed_in_filing Healthcare & Bio
topic_mentionATXIdiscussed_in_filing Sovereign & Government
topic_mentionATXIdiscussed_in_filing Cybersecurity
topic_mentionATXIdiscussed_in_filing Trusted Computing
topic_mentionATXIdiscussed_in_filing Blockchain & Crypto
topic_mentionATXIdiscussed_in_filing Regulation
topic_mentionATXIdiscussed_in_filing Healthcare & Bio
topic_mentionATXIdiscussed_in_filing Sovereign & Government
topic_mentionATXIdiscussed_in_filing Cybersecurity
topic_mentionATXIdiscussed_in_filing Trusted Computing
topic_mentionATXIdiscussed_in_filing Blockchain & Crypto
topic_mentionATXIdiscussed_in_filing Regulation
topic_mentionATXIdiscussed_in_filing Healthcare & Bio
topic_mentionATXIdiscussed_in_filing Sovereign & Government
topic_mentionATXIdiscussed_in_filing Cybersecurity
topic_mentionATXIdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001437749-26-010359EDGAR85K words
2025-03-312024-12-310001437749-25-010196EDGAR—
2024-03-182023-12-310001437749-24-008294EDGAR—
2023-03-312022-12-310001410578-23-000557EDGAR—
2022-03-252021-12-310001410578-22-000516EDGAR—
2021-03-312020-12-310001104659-21-044358EDGAR—
2020-03-302019-12-310001104659-20-040345EDGAR—
2019-03-122018-12-310001144204-19-013543EDGAR—
2018-03-012017-12-310001144204-18-012321EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001437749-25-034821EDGAR21K words
2025-08-142025-06-300001437749-25-026935EDGAR—
2025-05-152025-03-310001437749-25-017180EDGAR—
2024-11-142024-09-300001437749-24-035309EDGAR—
2024-08-092024-06-300001437749-24-025880EDGAR—
2024-05-152024-03-310001437749-24-017062EDGAR—
2023-11-132023-09-300001437749-23-031621EDGAR—
2023-08-112023-06-300001437749-23-023335EDGAR—
2023-05-122023-03-310001437749-23-014236EDGAR—
2022-11-102022-09-300001410578-22-003151EDGAR—
2022-08-152022-06-300001410578-22-002605EDGAR—
2022-05-162022-03-310001410578-22-001659EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-230001104659-26-018582EDGAR1K words
2025-12-310001104659-25-125420EDGAR—
2025-11-180001437749-25-035624EDGAR—
2025-11-120001437749-25-034243EDGAR—
2025-04-300001104659-25-042570EDGAR—
2025-03-170001104659-25-024505EDGAR—
2025-03-070001437749-25-006685EDGAR—
2024-11-290001104659-24-124081EDGAR—
2024-11-140001437749-24-035304EDGAR—
2024-09-270001437749-24-030185EDGAR—

188 total filings indexed. 157 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

specialty-pharmaceuticals hospital/inpatient-pain-management controlled-substance-analgesics

Company Identity

CIK0001644963
TickerATXI
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 583d550bee9b7b4c29d228e5c0fecb08ed05ce9a57384e6b0f706a500dc62874
parent: 012aa19980f044259b3874780d807055e779f9f289957ae5875daafe2838ec87
content hash: 2c460d24a072479e5344e92dfb877ec55bfebebfba27626b128f9d8a220dd398
signed: 2026-04-13T04:43:47.817Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf